Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Microglial Voltage-Gated Proton Channel Hv1 in Ischemic Stroke.
Neurological disorders: Differential methylation in multiple sclerosis.
Fertility treatment in spinal cord injury and other neurologic disease.
The radial diffusivity and magnetization transfer pool size ratio are sensitive markers for demyelination in a rat model of type III multiple sclerosis (MS) lesions.
Promoting remyelination for the treatment of multiple sclerosis: opportunities and challenges.
How does fingolimod (gilenya(®)) fit in the treatment algorithm for highly active relapsing-remitting multiple sclerosis?
pDC therapy induces recovery from EAE by recruiting endogenous pDC to sites of CNS inflammation.
Melatonin Lulling Th17 Cells to Sleep.
Retinal hemorrhages following fingolimod treatment for multiple sclerosis; a case report.
A new mechanism of nervous system plasticity: activity-dependent myelination.
Th17 cells in central nervous system autoimmunity.
Perceptions of using videogames in rehabilitation: a dual perspective of people with multiple sclerosis and physiotherapists.
Is There A Pulse Wave Encephalopathy Component To Multiple Sclerosis?
Dickkopf-3, a tissue-derived modulator of local T-cell responses.
Neuromyelitis optica spectrum disorders: beyond longitudinally extensive transverse myelitis.
Multiple sclerosis: Blood-based biomarkers provide insight into progressive MS.
Management of fatigue in persons with multiple sclerosis.
Exclusive use of alternative medicine as a positive choice: a qualitative study of treatment assumptions among people with multiple sclerosis in denmark.
Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy.
Persistence and pathogenesis of the neurotropic polyomavirus JC.
Multiple sclerosis following anti-tumor necrosis factor-alpha therapy for psoriasis: first case in Italy? Case report and review of the literature.
A Swiss real world best practice experience in three different clinical settings of the 6 hour fingolimod first dose observation procedure.
Impaired sleep-associated modulation of post-exercise corticomotor depression in multiple sclerosis.
Inhibition of Interferon regulatory factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis.
Aquaporin-4 autoimmunity.
Pages
« first
‹ previous
…
449
450
451
452
453
454
455
456
457
…
next ›
last »